Group Emotion-Focused Behavioral Intervention for Diabetes Distress in Type 2 Diabetes
Tests a group emotion-focused behavioral program for adults with type 2 diabetes and diabetes distress.
Key facts
- Who runs it
- Ohio State University
- Where
- Columbus, United StatesSee the site
- Trial code
- Registry title
- Group Emotion-Focused Behavioral Intervention for Diabetes Distress/A1c in T2D.
- Status
- Not yet recruiting
- People taking part
- 120 people, planned
- Started
- 1 Sept 2025
- Expected to end
- 31 Jan 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Group Emotion Focused Behavioral Intervention (G-EFBI)
- Group - With Every Heartbeat is Life (G-WEHL)
- Record updated
- 6 April 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with type 2 diabetes for at least one year who have high diabetes distress and blood sugar (A1c) above 7.5.
- Age
- Over 18 years
- Sex
- Men and women can join
- Disease stage
- Type 2 diabetes diagnosed at least one year ago, with stable other medical conditions
- Earlier treatment
- Must not have started psychotherapy or medicine for emotional issues within three months before joining
- Biomarker or test result
- A1c above 7.5 (with normal hemoglobin); Diabetes Distress Scale score above 2.0 on any subscale; PHQ-9 depression score below 15
Main reasons for not taking part
- Unstable medical conditions, for example a hospital stay in the past three months
- A psychotic disorder or an intellectual disability
- Started psychotherapy or medicine for emotional issues within three months
- Cannot read English
- Cannot give informed consent
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Male and female adults with documented diagnosis of T2D for at least one year
- Age > 18 years of age
- Diabetes Distress Scale score > 2.0 on any DDS subscale
- A1c > 7.5 (with hemoglobin in the normal range)
- PHQ-9 Depression score < 15
- Stable medical co-morbid conditions
- Absence of a psychotic disorder or an intellectual disability
- Able to read English
- Able to give informed consent
Who cannot take part
- Diabetes Distress Scale score < 2.0 on all DDS subscales
- Unstable medical co-morbid conditions (e.g., hospitalization in past three months)
- Presence of a psychotic disorder or an intellectual disability
- A1c < 7.5 (with hemoglobin in the normal range)
- Age < 18 years of age
- Male and female adults with documented diagnosis of T2D for less than one year
- PHQ-9 Depression score > 15
- Initiation of psychotherapy or pharmacotherapy for emotional issues within three months of study entry
- Unable to read English
- Unable to give informed consent
Where in United States
- The Ohio State University -Wexner Medical CenterColumbus, United StatesContact: Julian Roberts, R.N.Not yet recruiting
About the trial
What the trial wants to find out
T2D is a major public health problem and is currently the 7th leading cause of death in the US. Despite a range of efficacious treatments, less than 50% of patients achieve a glycemic target of A1c < 7.0%, suggesting that this is due to difficulty with following medical regimens to reduce A1C levels. While a range of factors have been identified in this regard, we posit that a barrier to treatment are broad difficulty with emotional regulation that are not diagnosis-specific but lead to Diabetes Distress (DD) and difficulty in coping with medical regimens, and other aspects of diabetes self-care, in the context of the psychosocial stressors associated with T2D. Extant data suggests that sub-optimal emotional regulation (experience of intense emotion and skill at regulating emotion) is related to elevated DD and A1c levels, and that an Emotion-Focused Behavioral Intervention (EFBI) can reduce both DD and A1c levels in PWD with T2D. In this project we seek to take our one-to-one intervention, now adapted to a group intervention (G-EFBI) and collect feasibility, acceptability, and preliminary efficacy data to determine if G-EFBI is a feasible, acceptable and, possibly, efficacious intervention compared to an "Attentional Control" intervention in PWD with T2D and elevated DD and A1c levels.
The 2 groups in the trial
- Group Emotion Focused Behavioral Intervention (G-EFBI)Treatment being tested
Group EFBI (G-EFBI) is a 10-session, 75-minute, program aimed at assisting people with T2D to gain knowledge about emotions and improve their ability to regulate and manage their emotions. G-EFBI begins with discussions regarding the relationship between events, feelings, and behaviors/actions and how this relates to diabetes management. The intervention moves to teaching participants: (1) how to identify emotions and understand their purpose; (2) learn how identifying the physiological/behavioral pattern of their own emotions; (3) learn the importance of recognizing emotions in themselves and in others; (4) learn strategies aimed at helping them to better cope and manage their emotions; (5) learn to use specific emotional restructuring strategies (i.e., reframing, finding the evidence) to change their negative emotional responses to daily stressors and events as it relates to diabetes management.
- G-WEHLExisting treatment, for comparison
To control for the effect of attention given to participants in G-EFBI that can result in psychosocial improvements, participants will be randomized to either G-EFBI or Group-With Every Heartbeat is Life (G-WEHL). G-WEHL is an educational intervention designed to increase awareness and prevention of cardiovascular disease. This intervention has ten 75-minute content sessions covering cardiovascular risk reduction in terms of diet, physical activity, and smoking cessation; the G-WEHL manual is provided in the Clinical Trials Section of this application; G-WEHL has no elements relevant to emotion regulation. The use of WEHL in this study is relevant because cardiovascular disease affects one-third of PWD, is a major cause of mortality (\~ 50%), and impact (20-49%) on direct medical costs of T2D.
Treatment: Group - With Every Heartbeat is Life (G-WEHL)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Development of a Group Emotion-Focused Behavioral Intervention for Diabetes Distress and Glycemic Management in Patients With T2D.
- Plain-language title
- Group Emotion-Focused Behavioral Intervention for Diabetes Distress in Type 2 DiabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 6 April 2025